Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

DCOY

Decoy Therapeutics Inc

Jun 01 • 04:00PM ET

8.36

-0.56 -6.28 %

Healthcare • Biotechnology • USA • Nano • NASD

Peers: APRE BCDA BIVI CALC CVM GOVX KAPA KPRX LNAI NEUP

| Held by: MEDX

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-124.04	Insider Own	5.56%	Shs Outstand	0.53M	Perf Week	14.52%
Market Cap	4.45M	Forward P/E	-	EPS next Y	-	Insider Trans	-0.09%	Shs Float	0.50M	Perf Month	38.18%
Enterprise Value	-3.37M	PEG	-	EPS next Q	-	Inst Own	0.30%	Short Float	1.70%	Perf Quarter	5.40%
Income	-13.03M	P/S	-	EPS this Y	-	Inst Trans	-1.67%	Short Ratio	0.36	Perf Half Y	-24.68%
Sales	0.00M	P/B	1.15	EPS next Y	-	ROA	-242.20%	Short Interest	0.01M	Perf YTD	7.38%
Book/sh	7.29	P/C	0.57	EPS next 5Y	-	ROE	-661.73%	52W High	415.80 -97.99%	Perf Year	-93.91%
Cash/sh	14.69	P/FCF	-	EPS past 3/5Y	81.80% 62.32%	ROIC	-336.14%	52W Low	4.32 93.51%	Perf 3Y	-99.61%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	- -	Gross Margin	-	Volatility	13.18% 11.06%	Perf 5Y	-99.98%
Dividend TTM	-	EV/Sales	-	EPS Y/Y TTM	86.68%	Oper. Margin	-	ATR (14)	0.73	Perf 10Y	-100.00%
Dividend Ex-Date	-	Quick Ratio	1.84	Sales Y/Y TTM	-	Profit Margin	-	RSI (14)	68.70	Recom	1.00
Dividend Gr. 3/5Y	- -	Current Ratio	1.84	EPS Q/Q	97.74%	SMA20	35.21%	Beta	0.57	Target Price	30.00
Payout	-	Debt/Eq	0.00	Sales Q/Q	-	SMA50	35.81%	Rel Volume	1.71	Prev Close	8.92
Employees	11	LT Debt/Eq	0.00	Earnings	Mar 30	SMA200	-62.48%	Avg Volume	23.63K	Price	8.36
IPO	Jan 29, 2015	Option/Short	No / Yes	EPS/Sales Surpr.	- -	Trades		Volume	40,105	Change	-6.28%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)